Trial Profile
A Phase I Single-Center, Randomized, Double-Blind, Placebo-Controlled, Combined Single Ascending Dose, Multiple Ascending Dose, and Food Effect Study to Investigate the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of K-755 in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs K-755 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors Kowa Pharmaceutical
- 27 Jan 2020 Status changed from recruiting to completed.
- 12 Sep 2019 Planned number of patients changed from 98 to 122.
- 12 Sep 2019 Planned End Date changed from 27 Feb 2020 to 31 Mar 2020.